by Rebecca Biason, University of Toronto People who develop rheumatoid arthritis as older adults benefit from early and sustained use of a drug called Methotrexate (MTX), a recent study led by University of Toronto researcher Jessica Widdifield has found. The study, the first of its kind to examine the evidence around the effect of timing of MTX initiation in relation to long-term...